Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Avantor, Inc.

Market Cap 6.41B 5.54B 5.11B 4.78B 8.97B 610B 9.1B 60.5B 23.54B 297B 24.06B 23.55B 1,027B P/E Ratio 2026 *
26.1x
P/E Ratio 2027 * 21.8x
Enterprise Value 9.42B 8.15B 7.5B 7.03B 13.18B 896B 13.38B 88.92B 34.6B 436B 35.36B 34.61B 1,509B EV / Sales 2026 *
1.45x
EV / Sales 2027 * 1.32x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 56 2023-08-06
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 6.41B
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
Average -0.32%+1.02%+1.25%-0.13% 56.71B
Weighted average by Cap. -0.45%-0.31%-7.88%+0.83%

Financials

2026 *2027 *
Net sales 6.5B 5.62B 5.18B 4.85B 9.09B 618B 9.23B 61.35B 23.87B 301B 24.4B 23.88B 1,041B 6.64B 5.74B 5.29B 4.95B 9.28B 631B 9.42B 62.63B 24.37B 307B 24.91B 24.38B 1,063B
Net income 245M 212M 195M 183M 343M 23.34B 348M 2.32B 901M 11.35B 921M 901M 39.32B 294M 254M 234M 219M 411M 27.96B 417M 2.77B 1.08B 13.6B 1.1B 1.08B 47.1B
Net Debt 3.01B 2.6B 2.4B 2.25B 4.21B 286B 4.28B 28.42B 11.06B 139B 11.3B 11.06B 482B 2.36B 2.04B 1.88B 1.76B 3.3B 225B 3.35B 22.29B 8.67B 109B 8.87B 8.68B 378B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!